M A TRADING & CONSULTANCY LIMITED

Company number 13957392 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

M A TRADING & CONSULTANCY LIMITED - Analysis Report

Company Number: 13957392

Analysis Date: 2025-07-29 19:11 UTC

Financial Health Assessment for M A TRADING & CONSULTANCY LIMITED


1. Financial Health Score: Grade D

Explanation:
M A TRADING & CONSULTANCY LIMITED is currently a dormant company with minimal financial activity reflected in its accounts. The company's net assets and shareholder funds are nominal (£1), indicating no meaningful business transactions or capital investment. Dormant status means no trading, revenue, or expenses have been recorded, which limits insight into operational health but also indicates lack of commercial activity. This places the company in a fragile financial health category, as it neither generates cash flow nor incurs liabilities, but also lacks growth or financial robustness.


2. Key Vital Signs

Metric Latest Data Interpretation
Company Status Active but Dormant No trading activity; no revenue or expenses
Net Assets £1 Minimal net worth, no capital accumulation
Share Capital £3 Very low capital invested
Shareholders' Funds £1 Equity reflects nominal value only
Filing Compliance Up to date No overdue filings; good administrative health
Control Single PSC with 75-100% shares Concentrated ownership, decision-making centralized
Industry Classification Management consultancy (non-financial) Intended consulting activity, currently inactive

Interpretation of Vital Signs:
The dormant status is the most critical "vital sign" here, akin to a patient in a medically induced coma—no active metabolism (business operations) but not deceased either. The balance sheet shows a static and negligible financial position with no working capital, no liabilities, and no trading history. Compliance with filing deadlines is a positive sign, indicating good governance despite inactivity.


3. Diagnosis

Underlying Business Health:

  • The company is effectively in a state of financial hibernation.
  • No operating cash flow or business activity means there are no symptoms of distress such as debt accumulation or losses, but also no signs of growth or financial strength.
  • The nominal net assets and equity resemble a patient with extremely low blood pressure—there’s no circulation of funds or capital to support business functions.

Risks:

  • Prolonged dormancy can lead to erosion of market presence and potential loss of key personnel or business opportunities.
  • Lack of trading activity might cause challenges if the company plans to restart operations, including potential difficulties accessing finance or contracts without a trading track record.

Strengths:

  • The company is fully compliant with statutory filing requirements, which demonstrates good administrative discipline and reduces risk of penalties or regulatory issues.
  • The ownership and control structure is clear and centralized, allowing for swift decision-making if business activity resumes.

4. Recommendations

To improve the company’s financial wellness and prepare for future operations, consider the following steps:

  1. Activate Business Operations:
    Begin trading activities to generate revenue and create positive cash flow, which will improve net assets and shareholder funds. Dormancy is a temporary state, so initiating business will reintroduce "blood flow" into the company.

  2. Capitalize Adequately:
    Inject sufficient capital to support initial operating costs and working capital needs. This will build a healthier balance sheet and provide a buffer against early-stage expenses.

  3. Maintain Compliance:
    Continue timely filing of accounts and confirmation statements to avoid penalties. Good administrative health supports overall company wellness.

  4. Financial Planning:
    Develop a budget and cash flow forecast to monitor liquidity, ensuring the company maintains "healthy circulation" of funds. This will help identify potential financial bottlenecks early.

  5. Consider Strategic Review:
    Evaluate the company’s business model and market positioning to ensure viability and growth potential before significant financial commitment.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.